Amgen
AMGN
#101
Rank
$163.22 B
Marketcap
$303.56
Share price
0.75%
Change (1 day)
-8.71%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Number of shares outstanding for Amgen (AMGN)

Number of shares outstanding as of July 2025 : 538,000,000

According to Amgen's latest financial reports and stock price the company's current number of shares outstanding is 538,000,000. At the end of 2025 the company had 538,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Amgen from 2000 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.53 B0.19%
20240.53 B0.37%
20230.53 B0%
20220.53 B-4.8%
20210.56 B-3.27%
20200.58 B-2.02%
20190.59 B-6.61%
20180.63 B-12.29%
20170.72 B-2.43%
20160.74 B-1.59%
20150.75 B-0.92%
20140.76 B0.93%
20130.75 B-1.18%
20120.76 B-15.88%
20110.90 B-5.32%
20100.95 B-5.71%
20091.01 B-3.97%
20081.05 B-2.58%
20071.08 B-6.94%
20061.16 B-5.35%
20051.23 B-3.07%
20041.27 B-1.32%
20031.28 B3.81%
20021.24 B18.45%
20011.04 B1.57%
20001.03 B1.04%
19991.02 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Pfizer
PFE
5,675,000,000 954.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,031,000,000 277.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2,038,500,000 278.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
1,246,000,000 131.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
146,100,000-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,768,000,000 228.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
2,405,625,000 347.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
159,000,000-70.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
897,989,151 66.91%๐Ÿ‡บ๐Ÿ‡ธ USA